UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058906
Receipt number R000067368
Scientific Title The efficacy and safety of thulium fiber laser and flexible and navigable suction ureteral access sheath in retrograde intrarenal surgery for renal stone, compared with conventional access sheath: A Japanese multicenter prospective randomized controlled trial (TFLFANSJapan trial)
Date of disclosure of the study information 2025/08/27
Last modified on 2025/08/27 09:00:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The efficacy and safety of thulium fiber laser and flexible and navigable suction ureteral access sheath in retrograde intrarenal surgery for renal stone, compared with conventional access sheath: A Japanese multicenter prospective randomized controlled trial (TFLFANSJapan trial)

Acronym

TFLFANSJapan trial

Scientific Title

The efficacy and safety of thulium fiber laser and flexible and navigable suction ureteral access sheath in retrograde intrarenal surgery for renal stone, compared with conventional access sheath: A Japanese multicenter prospective randomized controlled trial (TFLFANSJapan trial)

Scientific Title:Acronym

TFLFANSJapan trial

Region

Japan


Condition

Condition

renal stone

Classification by specialty

Urology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

This study aims to compare the efficacy and safety of thulium fiber laser and flexible and navigable suction ureteral access sheath in retrograde intrarenal surgery for renal stone, compared with conventional access sheath.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Stone-free status at one month postoperatively by CT

Key secondary outcomes

Operative time
Comparison of surgical complications such as fever and hydronephrosis
laser time
Lithotripsy effectiveness
Laser ablation speed
Laser ablation efficiency


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration


Blocking

YES

Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

thulium fiber laser and flexible and navigable suction ureteral access sheath in retrograde intrarenal surgery for renal stone

Interventions/Control_2

thulium fiber laser and conventional access sheath in retrograde intrarenal surgery for renal stone

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Patient with renal stones (stone diameter 10-20 mm) (if multiple renal stones are present, the largest diameter must be 10-20 mm)
Patient deemed eligible for one stage RIRS
Patient for whom written consent to participate in this study has been obtained from the patient themselves, their guardian, or authorized representative

Key exclusion criteria

Patient with anomaly genitourinary system
Patient with ureteral stone

Target sample size

130


Research contact person

Name of lead principal investigator

1st name Go
Middle name
Last name Anan

Organization

Yotsuya Medical Cube

Division name

Urology

Zip code

1020084

Address

7-7 Nibancho, Chiyoda-ku, Tokyo

TEL

03-3261-0401

Email

g-anan@mcube.jp


Public contact

Name of contact person

1st name Go
Middle name
Last name Anan

Organization

Yotsuya Medical Cube

Division name

Urology

Zip code

1020084

Address

7-7 Nibancho, Chiyoda-ku, Tokyo

TEL

03-3261-0401

Homepage URL


Email

g-anan@mcube.jp


Sponsor or person

Institute

Clinical Research Management Department, Yotsuya Medical Cube

Institute

Department

Personal name



Funding Source

Organization

self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Hachinohe Heiwa Hospital, Ohguchi Higashi General Hospital, Tsukuba Memorial Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Clinical Research Management Department, Yotsuya Medical Cube

Address

7-7 Nibancho, Chiyoda-ku, Tokyo

Tel

03-3261-0401

Email

ymc_rinsyou@mcube.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 08 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 06 Month 06 Day

Date of IRB

2025 Year 06 Month 06 Day

Anticipated trial start date

2025 Year 09 Month 01 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 08 Month 27 Day

Last modified on

2025 Year 08 Month 27 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067368